"Analysis.group","Analysis.number","Analysis.name","Subgroup","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","Bias.arising.from.the.randomization.process.judgement","Bias.arising.from.the.randomization.process.support","Bias.due.to.deviations.from.intended.interventions.judgement","Bias.due.to.deviations.from.intended.interventions.support","Bias.due.to.missing.outcome.data.judgement","Bias.due.to.missing.outcome.data.support","Bias.in.measurement.of.the.outcome.judgement","Bias.in.measurement.of.the.outcome.support","Bias.in.selection.of.the.reported.result.judgement","Bias.in.selection.of.the.reported.result.support","Overall.bias.judgement","Overall.bias.support","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
1,5,"Number of participants withdrawing due to an adverse event at 12 weeks","","SUBGROUP_AND_OVERALL","Paterson 2022",2022,0,0,0,0,1,47,0,0,0,41,0,0,100,6.5035,0.127871,330.766169,NA,"Low risk","<p>The randomisation schedule was prepared by a biostatistician. Participants were randomised on a 1:1 ratio with random permuted block sizes. There were no meaningful differences between groups at baseline.</p>","Low risk","<p>Participants were blinded to treatment allocation. It was not possible to blind carers giving the intervention. Treatment credibility and expectancy was not different between groups. Intervention adherence was the same for both groups.</p>","Low risk","<p>At 12 weeks, 87 (99%) participants had completed primary outcomes.</p>","Low risk","<p>Reliable and valid measures were used. Participants were blinded to allocation and the outcome was patient-reported. Outcome assessors were blinded.</p>","Low risk","<p>A protocol was published and the trial was prospectively registered with a clinical trials registry. All eligible results for this outcome correspond to all intended outcome measurements outlined in the protocol and registry. All eligible results for this outcome correspond to all intended analyses outlined in the protocol and registry.</p>","Low risk","<p>All domains judged to be of low risk of bias.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007809.pub3/full","10.1002/14651858.CD007809.pub3","5::overall","CD007809_pub3_data","direction_only",FALSE,FALSE,FALSE,-0.0174567850363667,0.000485757686014773,-0.601596877800124,0.56668330772739,-0.0827822502562498,0.0837537656282793,TRUE,TRUE
2,5,"Number of participants reporting an adverse event","4 weeks","SUBGROUP_AND_OVERALL","Munteanu 2021",2021,0,0,0,0,23,49,0,0,18,51,0,0,100,1.621795,0.726635,3.619723,NA,"Low risk","<p>Participants were allocated to the intervention or control groups using minimisation incorporating stratifications by age and sex, using an interactive voice response telephone service. There were no meaningful differences between groups at baseline.</p>","Low risk","<p>Participants were blinded to treatment allocation. It was not possible to blind carers giving the intervention. Treatment credibility and expectancy was not different between groups. Intervention adherence was the same for both groups.</p>","Low risk","<p>13 out of 100 failed to provide outcome data at 12 weeks. There were no analysis methods that corrected for missing data. It's unlikely that missingness in the outcome was due to its true value. An equal number of participants from both groups did not provide outcome data at 12 weeks.</p>","Low risk","<p>Reliable and valid measures were used. Participants were blinded to allocation and the outcome was patient reported. Outcome assessors were blinded. Comparable methods of outcome measurement involved the same measurement methods used at comparable time points.&nbsp;</p>","Low risk","<p>A protocol published and the trial was prospectively registered with a clinical trials registry. All eligible results for this outcome correspond to all intended outcome measurements outlined in the protocol and registry. All eligible results for this outcome correspond to all intended analyses outlined in the protocol and registry.</p>","Low risk","<p>All domains judged to be of low risk of bias.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007809.pub3/full","10.1002/14651858.CD007809.pub3","5::overall","CD007809_pub3_data","direction_only",FALSE,FALSE,FALSE,-0.0174567850363667,0.000485757686014773,-0.601596877800124,0.56668330772739,-0.0827822502562498,0.0837537656282793,TRUE,TRUE
2,5,"Number of participants reporting an adverse event","52 weeks","SUBGROUP_AND_OVERALL","Munteanu 2021",2021,0,0,0,0,42,49,0,0,41,51,0,0,100,1.463415,0.508331,4.212966,NA,"Low risk","<p>Participants were allocated to the intervention or control groups using minimisation incorporating stratifications by age and sex, using an interactive voice response telephone service. There were no meaningful differences between groups at baseline.</p>","Low risk","<p>Participants were blinded to treatment allocation. It was not possible to blind carers giving the intervention. Treatment credibility and expectancy was not different between groups. Intervention adherence was the same for both groups.</p>","Low risk","<p>13 out of 100 failed to provide outcome data at 12 weeks. There were no analysis methods that corrected for missing data. It's unlikely that missingness in the outcome was due to its true value. An equal number of participants from both groups did not provide outcome data at 12 weeks.</p>","Low risk","<p>Reliable and valid measures were used. Participants were blinded to allocation and the outcome was patient reported. Outcome assessors were blinded. Comparable methods of outcome measurement involved the same measurement methods used at comparable time points.&nbsp;</p>","Low risk","<p>A protocol published and the trial was prospectively registered with a clinical trials registry. All eligible results for this outcome correspond to all intended outcome measurements outlined in the protocol and registry. All eligible results for this outcome correspond to all intended analyses outlined in the protocol and registry.</p>","Low risk","<p>All domains judged to be of low risk of bias.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007809.pub3/full","10.1002/14651858.CD007809.pub3","5::overall","CD007809_pub3_data","direction_only",FALSE,FALSE,FALSE,-0.0174567850363667,0.000485757686014773,-0.601596877800124,0.56668330772739,-0.0827822502562498,0.0837537656282793,TRUE,TRUE
2,5,"Number of participants reporting an adverse event","12 weeks","SUBGROUP_AND_OVERALL","Munteanu 2021",2021,0,0,0,0,29,49,0,0,31,51,0,0,100,0.935484,0.420201,2.082645,NA,"Low risk","<p>Participants were allocated to the intervention or control groups using minimisation incorporating stratifications by age and sex, using an interactive voice response telephone service. There were no meaningful differences between groups at baseline.</p>","Low risk","<p>Participants were blinded to treatment allocation. It was not possible to blind carers giving the intervention. Treatment credibility and expectancy was not different between groups. Intervention adherence was the same for both groups.</p>","Low risk","<p>13 out of 100 failed to provide outcome data at 12 weeks. There were no analysis methods that corrected for missing data. It's unlikely that missingness in the outcome was due to its true value. An equal number of participants from both groups did not provide outcome data at 12 weeks.</p>","Low risk","<p>Reliable and valid measures were used. Participants were blinded to allocation and the outcome was patient reported. Outcome assessors were blinded. Comparable methods of outcome measurement involved the same measurement methods used at comparable time points.&nbsp;</p>","Low risk","<p>A protocol published and the trial was prospectively registered with a clinical trials registry. All eligible results for this outcome correspond to all intended outcome measurements outlined in the protocol and registry. All eligible results for this outcome correspond to all intended analyses outlined in the protocol and registry.</p>","Low risk","<p>All domains judged to be of low risk of bias.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007809.pub3/full","10.1002/14651858.CD007809.pub3","5::overall","CD007809_pub3_data","direction_only",FALSE,FALSE,FALSE,-0.0174567850363667,0.000485757686014773,-0.601596877800124,0.56668330772739,-0.0827822502562498,0.0837537656282793,TRUE,TRUE
3,5,"Quality of life (SF-36 - Bodily Pain)","1 month","SUBGROUP_AND_OVERALL","Munteanu 2011",2011,0,0,71.9,16.8,0,75,67.1,21.9,0,76,0,0,100,4.8,-1.420797,11.020797,NA,"Low risk","<p>Participants were randomly allocated to receive hylan G-F 20 (Synvisc) or saline (placebo) using a computer-generated &nbsp;random number sequence. Randomisation was performed using sealed opaque, identical envelopes. There were no clinically significant baseline differences.</p>","Low risk","<p>Assessors and participants were blinded to group allocation. However, interventional radiologists were aware of the assigned intervention.</p>","High risk","<p>24 participants (16%) dropped-out at 3 months. ITT analysis was used (but last score carried forward method). It is possible that missing outcome data could have resulted from a poor or excellent outcome.<br>&nbsp;</p>","Low risk","<p>Outcomes were appropriate - reliable and valid. Both participants and assessors were blinded. Assessors were blinded.</p>","Low risk","<p>A pre-specified analysis was prepared and followed as per the published trial protocol. In addition, trial was registed with ANZCTR.</p>","High risk","<p>One domain judged to be of high risk of bias.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007809.pub3/full","10.1002/14651858.CD007809.pub3","5::overall","CD007809_pub3_data","direction_only",FALSE,FALSE,FALSE,-0.0174567850363667,0.000485757686014773,-0.601596877800124,0.56668330772739,-0.0827822502562498,0.0837537656282793,TRUE,TRUE
3,5,"Quality of life (SF-36 - Bodily Pain)","6 months","SUBGROUP_AND_OVERALL","Munteanu 2011",2011,0,0,65.8,21.8,0,75,70.7,20.9,0,76,0,0,100,-4.9,-11.713246,1.913246,NA,"Low risk","<p>Participants were randomly allocated to receive hylan G-F 20 (Synvisc) or saline (placebo) using a computer-generated &nbsp;random number sequence. Randomisation was performed using sealed opaque, identical envelopes. There were no clinically significant baseline differences.</p>","Low risk","<p>Assessors and participants were blinded to group allocation. However, interventional radiologists were aware of the assigned intervention.</p>","High risk","<p>24 participants (16%) dropped-out at 3 months. ITT analysis was used (but last score carried forward method). It is possible that missing outcome data could have resulted from a poor or excellent outcome.<br>&nbsp;</p>","Low risk","<p>Outcomes were appropriate - reliable and valid. Both participants and assessors were blinded. Assessors were blinded.</p>","Low risk","<p>A pre-specified analysis was prepared and followed as per the published trial protocol. In addition, trial was registed with ANZCTR.</p>","High risk","<p>One domain judged to be of high risk of bias.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007809.pub3/full","10.1002/14651858.CD007809.pub3","5::overall","CD007809_pub3_data","direction_only",FALSE,FALSE,FALSE,-0.0174567850363667,0.000485757686014773,-0.601596877800124,0.56668330772739,-0.0827822502562498,0.0837537656282793,TRUE,TRUE
3,5,"Quality of life (SF-36 - Bodily Pain)","3 months","SUBGROUP_AND_OVERALL","Munteanu 2011",2011,0,0,72.4,19.5,0,75,69.8,22,0,76,0,0,100,2.6,-4.028742,9.228742,NA,"Low risk","<p>Participants were randomly allocated to receive hylan G-F 20 (Synvisc) or saline (placebo) using a computer-generated &nbsp;random number sequence. Randomisation was performed using sealed opaque, identical envelopes. There were no clinically significant baseline differences.</p>","Low risk","<p>Assessors and participants were blinded to group allocation. However, interventional radiologists were aware of the assigned intervention.</p>","High risk","<p>24 participants (16%) dropped-out at 3 months. ITT analysis was used (but last score carried forward method). It is possible that missing outcome data could have resulted from a poor or excellent outcome.<br>&nbsp;</p>","Low risk","<p>Outcomes were appropriate - reliable and valid. Both participants and assessors were blinded. Assessors were blinded.</p>","Low risk","<p>A pre-specified analysis was prepared and followed as per the published trial protocol. In addition, trial was registed with ANZCTR.</p>","High risk","<p>One domain judged to be of high risk of bias.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007809.pub3/full","10.1002/14651858.CD007809.pub3","5::overall","CD007809_pub3_data","direction_only",FALSE,FALSE,FALSE,-0.0174567850363667,0.000485757686014773,-0.601596877800124,0.56668330772739,-0.0827822502562498,0.0837537656282793,TRUE,TRUE
4,5,"Number of participants reporting an adverse event at 12 weeks","12 weeks","SUBGROUP_AND_OVERALL","Menz 2016",2016,0,0,0,0,7,52,0,0,15,46,0,0,100,0.412821,0.184628,0.923049,NA,"Low risk","<p>The allocation sequence was random and concealed. There were no baseline differences between groups.</p>","Low risk","<p>Participants could not be blinded. Research staff could not be blinded. There were no deviations from the intended intervention due to the experimental context.</p>","High risk","<p>Data were not available for 5 (~10%) of participants in the orthoses group and for 5 (~11%) participants in the footwear group at 12 weeks. It is likely that missingness depended on the true value.</p>","Some concerns","<p>Method of measuring the outcome was appropriate and did not differ between groups. However, outcome assessors were aware of the intervention received, and this knowledge could have influenced their assessment.</p>","Low risk","<p>Trial was regsistered and protocol published before trial started. A pre-specified analysis was prepared and followed.It is clear that all reported results correspond to the intended outcome measurements. It is clear that all reported results correspond to the intended analyses.&nbsp;</p>","High risk","<p>At least one domain judged to be of high risk of bias.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007809.pub3/full","10.1002/14651858.CD007809.pub3","5::overall","CD007809_pub3_data","direction_only",FALSE,FALSE,FALSE,-0.0174567850363667,0.000485757686014773,-0.601596877800124,0.56668330772739,-0.0827822502562498,0.0837537656282793,TRUE,TRUE
5,5,"Quality of life (SF-36 - Physical Functioning) at 2 weeks","","SUBGROUP_AND_OVERALL","Çıra 2022",2022,0,0,61.3,17.1,0,40,50.5,17.8,0,40,0,0,100,10.8,3.150803,18.449197,NA,"Some concerns","<p>Randomisation appears to have occurred - a coin toss was used to allocate. No information about whether allocation was concealed. No information provided for the participants who were randomised (n=90) - only information for those that completed the trial (n=80).</p>","","","","","","","","","","","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007809.pub3/full","10.1002/14651858.CD007809.pub3","5::overall","CD007809_pub3_data","direction_only",FALSE,FALSE,FALSE,-0.0174567850363667,0.000485757686014773,-0.601596877800124,0.56668330772739,-0.0827822502562498,0.0837537656282793,TRUE,TRUE
